MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of 42.79 million. The enterprise value is 53.76 million.
| Market Cap | 42.79M |
| Enterprise Value | 53.76M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedMira has 701.73 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 701.73M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 209.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 223.78 |
| PB Ratio | -3.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.46 |
| EV / Sales | 270.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.67 |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.74 |
| Interest Coverage | -3.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -52.20% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 20.55% |
| Revenue Per Employee | 3,677 |
| Profits Per Employee | -59,203 |
| Employee Count | 52 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 4.51 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.50% in the last 52 weeks. The beta is 14.15, so MedMira's price volatility has been higher than the market average.
| Beta (5Y) | 14.15 |
| 52-Week Price Change | -65.50% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 37.76 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of 191,206 and -3.08 million in losses. Loss per share was -0.00.
| Revenue | 191,206 |
| Gross Profit | -477,317 |
| Operating Income | -2.50M |
| Pretax Income | -3.08M |
| Net Income | -3.08M |
| EBITDA | -2.44M |
| EBIT | -2.50M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 204,255 in cash and 10.77 million in debt, giving a net cash position of -10.57 million or -0.02 per share.
| Cash & Cash Equivalents | 204,255 |
| Total Debt | 10.77M |
| Net Cash | -10.57M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -14.19M |
| Book Value Per Share | -0.02 |
| Working Capital | -13.71M |
Cash Flow
In the last 12 months, operating cash flow was -2.36 million and capital expenditures -515,572, giving a free cash flow of -2.88 million.
| Operating Cash Flow | -2.36M |
| Capital Expenditures | -515,572 |
| Free Cash Flow | -2.88M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | -249.64% |
| Operating Margin | -1,307.39% |
| Pretax Margin | -1,610.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.57% |
| Earnings Yield | -7.19% |
| FCF Yield | -6.73% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedMira has an Altman Z-Score of -41.51. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -41.51 |
| Piotroski F-Score | n/a |